Cefazolin Sodium

Specifications

27164-46-1CAS Number

248-278-4EC Number

sodium (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateIUPAC Name

C14H13N8NaO4S3Chemical Formula

476.5 g/molMolecular Weight

CEFAZOLIN SODIUM; 27164-46-1; Cefazolin sodium salt; Cefazoline sodium; Totacef; Ancef; Cefacidal; Cefamedin; Gramaxin; Zolicef; Cefazil; Kefzol; Sodium cefazolin; Sodium cephazolin; Monosodium cefazolin; Cephazolin Sodium; Cefazolin injection; SK&F 41558; CEFAZOLIN AND DEXTROSE; ANCEF IN PLASTIC CONTAINER; SKF 41558; NSC-291561; P380M0454Z; CHEBI:3483; DTXSID901015786; ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER; ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER; NSC291561; Sodium, Cefazolin; Cephazolin, Sodium; Sodium, Cephazolin; RefChem:54732; DTXCID001473947; CEFAZOLIN IN PLASTIC CONTAINER; (6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, Sodium Salt; Monosodium (6R,7R)-3-(5-methyl-1,3,4-thiadiazol-2-ylsulfanylmethyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetylamino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Cefazolin (sodium); Cefazina; Firmacef; Liviclina; Atirin; Acef; MFCD00056883; MLS000028706; Biazolina; SMR000058708; Sodium CEZ; 7-epi-Cefazolin Sodium Salt; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-, sodium salt (1:1), (6R,7R)-; Cefabiozim; Cefalomicina; Lampocef; Neofazol; Zolisint; Recef; Zolin; Bor-Cefazol; CEZ sodium; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, monosodium salt (6R-trans)-; Sodium (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Sodium (6R-trans)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Lilly 46083; UNII-P380M0454Z; Cefazolin sodium [USAN:USP:JAN]; Monosodium (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Monosodium (6R,7R)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[2-(1H-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Sodium (6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Prestwick_975; EINECS 248-278-4; Ancef (TN); NSC 291561; Opera_ID_1323; Cefazolin Sodium (sterile); MSK7014Na; SCHEMBL40735; SPECTRUM1500164; Cefazolin (sodium) (Standard); CEFAZOLIN SODIUM [JAN]; Cefazolin sodium (JP18/USP); orb1225458; orb1310135; orb3139407; Sodium CEZ; SKF-41558; CEFAZOLIN SODIUM [USAN]; CEFAZOLIN SODIUM [VANDF]; CHEMBL1200523; HMS500A16; HY-B1078R; CEFAZOLIN SODIUM [MART.]; CEFAZOLIN SODIUM [WHO-DD]; FLKYBGKDCCEQQM-WYUVZMMLSA-M; HMS1570C14; HMS1920K07; HMS2091A10; HMS2097C14; HMS2230I22; HMS3260H10; HMS3714C14; CEFAZOLIN SODIUM SALT [MI]; HY-B1078; sodium (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[2-(1H-1,2,3,4-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Tox21_500274; CCG-40011; EBC-08481; AKOS015895533; CEFAZOLIN SODIUM [ORANGE BOOK]; AC19848; CEFAZOLIN SODIUM [EP MONOGRAPH]; CS-4634; LP00274; CEFAZOLIN SODIUM [USP MONOGRAPH]; Cefazolin sodium salt, 89.1-110.1%; NCGC00022653-19; NCGC00093731-01; NCGC00260959-01; 3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-cephem-4-carboxylate; AC-13166; AC-31729; AS-12230; DA-62213; Sodium (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; ST024775; EU-0100274; T0953; C 5020; C08098; D00905; EN300-6731106; Cefazolin sodium 100 |Ig/mL in Acetonitrile/Water; Cefazolin sodium 100 microg/mL in Acetonitrile/Water; Q27106104; Z2756516844; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, (6R-trans)-, sodium salt; 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-, monosodium salt, (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-, sodium salt, (6R,7R)- (1:1); 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-,(6R,7R)-,sodium; sodium (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Sodium (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[2-(1H-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; sodium 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylate; sodium 7beta-(1H-tetrazol-1-yl)acetamido-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate; sodium 7beta-[2-(1H-tetrazol-1-yl)-acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate; sodium 7beta-[2-(1H-tetrazol-1-yl)acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylateSynonyms